The day prior to the MPNAE&I Patient Program in Melbourne, Australian MPN clinicians and researchers met with some US counterparts to share knowledge and ideas. In the photo below, Dr Ruben Mesa speaks about the unmet needs of MPN patients, particularly those with Myelofibrosis. He discussed the role of Ruxolitinib, Interferon and clinical trials. He addressed the question of what would constitute failure of Ruxolitinib treatment, and when it might be appropriate to continue Ruxolitinib despite suboptimal symptom or spleen control, or hematological toxicity in this group of patients. Thanks again to Ann Brazeau and MPNAE&I for making this possible.
https://www.mpnallianceaustralia.org.au/wp-content/uploads/2018/07/favicon-mpn-aa.png 430 430 Sue https://www.mpnallianceaustralia.org.au/wp-content/uploads/2018/07/logo-mpn-aa-july-2018.svg Sue2017-05-03 14:00:092018-10-02 15:00:17MPN Clinicians and Researchers meeting – Melbourne 27 April 2017